Table 1 |
||||
|
Serologic associations observed in SLE patients in the replication cohort, best fit model from logistic regression |
||||
|
Locus and Allele |
Associated Antibody Profile |
Ancestral Background |
Odds Ratio (95% CI) |
P-value |
|
|
||||
|
LRRC20 rs10762360 G |
Anti-La |
AA |
2.40 (1.51 to 3.81) |
1.6 × 10-4 |
|
PPM1 H rs10784318 C |
Anti-La |
EA and HA joint |
3.74 (1.88 to 7.47) |
3.6 × 10-5 |
|
LPAR1 rs10980684 T |
Anti-Ro with Anti-Sm |
AA and HA joint |
2.22 (1.42 to 3.47) |
1.2 × 10-4 |
|
ANKS1A rs2820223 C |
Anti-Ro with Anti-dsDNA |
AA |
3.14 (1.68 to 5.87) |
3.5 × 10-4 |
|
PTPRM rs17494870 C |
- |
- |
- |
- |
|
EFNA5 rs26725 C |
Anti-RNP |
AA |
1.73 (1.10 to 2.72) |
0.018 |
|
VSIG2 rs11219769 T |
Anti-RNP lacking Anti-Sm |
EA and HA joint |
3.99 (1.81 to 8.75) |
2.1 × 10-4 |
|
|
||||
|
AA, African-American, EA, European-American, HA, Hispanic-American, 95% CI, 95% confidence interval; "joint" indicates that two or more ancestral backgrounds showed a similar tendency when analyzed separately with a non-significant difference observed between odds ratios, and that the indicated ancestral backgrounds were analyzed jointly using a fixed-effects model. |
||||
|
Kariuki et al. Arthritis Research & Therapy 2010 12:R151 doi:10.1186/ar3101 |
||||